nach oben

Urolithiasis

Erschienen in:

07.11.2018 | Letter to the Editor

Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation

verfasst von: M. Bargagli, G. Primiano, A. Primiano, J. Gervasoni, A. Naticchia, S. Servidei, G. Gambaro, P. M. Ferraro

Erschienen in: Urolithiasis | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Lightowlers RN, Taylor RW, Turnbull DM (2015) Mutations causing mitochondrial disease: what is new and what challenges remain? Science 349:1494–1499. https://doi.org/10.1126/science.aac7516 CrossRefPubMed

DiMauro S, Schon EA, Carelli V, Hirano M (2013) The clinical maze of mitochondrial neurology. Nat Rev Neurol 9:429–444. https://doi.org/10.1038/nrneurol.2013.126 CrossRefPubMedPubMedCentral

Emma F, Montini G, Parikh SM, Salviati L (2016) Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol 12:267–280. https://doi.org/10.1038/nrneph.2015.214 CrossRefPubMedPubMedCentral

Emma F, Bertini E, Salviati L, Montini G (2012) Renal involvement in mitochondrial cytopathies. Pediatr Nephrol Berl Ger 27:539–550. https://doi.org/10.1007/s00467-011-1926-6 CrossRef

Pickett SJ, Grady JP, Ng YS et al (2018) Phenotypic heterogeneity in m.3243A>G mitochondrial disease: the role of nuclear factors. Ann Clin Transl Neurol 5:333–345. https://doi.org/10.1002/acn3.532 CrossRefPubMedPubMedCentral

Mancuso M, Orsucci D, Angelini C et al (2014) The m.3243A >G mitochondrial DNA mutation and related phenotypes. A matter of gender? J Neurol 261:504–510. https://doi.org/10.1007/s00415-013-7225-3 CrossRefPubMed

Hotta O, Inoue CN, Miyabayashi S et al (2001) Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int 59:1236–1243. https://doi.org/10.1046/j.1523-1755.2001.0590041236.x CrossRefPubMed

Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann NY Acad Sci 1142:133–158. https://doi.org/10.1196/annals.1444.011 CrossRefPubMed

Gafni RI, Brahim JS, Andreopoulou P et al (2012) Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res 27:1811–1820. https://doi.org/10.1002/jbmr.1627 CrossRefPubMedPubMedCentral

10.

Miller PD, Bilezikian JP, Diaz-Curiel M et al (2009) Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2006-2439 CrossRefPubMedPubMedCentral

11.

Chow J, Rahman J, Achermann JC et al (2017) Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol 13:92–104. https://doi.org/10.1038/nrendo.2016.151 CrossRefPubMed

12.

Tanaka K, Takada Y, Matsunaka T et al (2000) Diabetes mellitus, deafness, muscle weakness and hypocalcemia in a patient with an A3243G mutation of the mitochondrial DNA. Intern Med Tokyo Jpn 39:249–252CrossRef

13.

O’Toole JF (2014) Renal manifestations of genetic mitochondrial disease. Int J Nephrol Renov Dis 7:57–67. https://doi.org/10.2147/IJNRD.S37887 CrossRef

14.

Nota B, Struys EA, Pop A et al (2013) Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria. Am J Hum Genet 92:627–631. https://doi.org/10.1016/j.ajhg.2013.03.009 CrossRefPubMedPubMedCentral

15.

Gafni RI, Langman CB, Guthrie LC et al Hypocitraturia is an untoward side effect of synthetic human parathyroid hormone (hPTH) 1-34 therapy in hypoparathyroidism that may increase renal morbidity. J Bone Miner Res 0: https://doi.org/10.1002/jbmr.3480 CrossRef

16.

Gambaro G, Vezzoli G, Casari G et al (2004) Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 44:963–986CrossRef

Titel: Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation
verfasst von: M. Bargagli
G. Primiano
A. Primiano
J. Gervasoni
A. Naticchia
S. Servidei
G. Gambaro
P. M. Ferraro
Publikationsdatum: 07.11.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Urolithiasis / Ausgabe 5/2019
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-018-1087-1

Neu im Fachgebiet Urologie

24.04.2024 | DGIM 2024 | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation

Excerpt

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

Protective effect of pentoxifylline on oxidative renal cell injury associated with renal crystal formation in a hyperoxaluric rat model

Vision for the future on urolithiasis: research, management, education and training—some personal views

Impact of surgeon’s experience on outcome parameters following ureterorenoscopic stone removal

Factors affecting infectious complications following flexible ureterorenoscopy

Antepartum nephrolithiasis and the risk of preterm delivery

A case of allograft ureteral stone successfully treated with antegrade ureteroscopic lithotripsy: use of a 3D-printed model to determine the ideal approach

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie